Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clearbridge HealthSGX:1H3 Days Payable is 200.52 as of Jun. 2026, which is 188% above its 10-year median of 69.55. The stock has 4 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Clearbridge Health ranks better than 57.89% on this metric.
The historical rank and industry rank for Clearbridge Health's Days Payable or its related term are showing as below:
SGX:1H3'
s Days Payable Range Over the Past 10 Years
Min: 37.68 Med: 69.55 Max: 4440.83
Current: 85.8
During the past 12 years, Clearbridge Health's highest Days Payable was 4440.83. The lowest was 37.68. And the median was 69.55.
SGX:1H3's Days Payable is ranked better than 57.89% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.005
vs SGX:1H3: 85.80
Clearbridge Health's Days Payable
increased
from Jun. 2025 (118.25) to Jun. 2026 (200.52).
It may suggest that Clearbridge Healthdelayed paying its suppliers.
The historical data trend for Clearbridge Health's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:1H3 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Clearbridge Health's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clearbridge Health Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's Days Payable distribution charts can be found below:
* The bar in red indicates where Clearbridge Health's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Clearbridge Health's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clearbridge Health (SGX:1H3) has a Days Payable of 200.52 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clearbridge Health and its competitors. This is 188% above median its historical median of 69.55. Over the past decade, Clearbridge Health's Days Payable has ranged from 37.68 to 4,440.83. According to the industry distribution chart, Clearbridge Health ranks #80 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 42.1%.
Is Clearbridge Health's Days Payable too high?
Clearbridge Health's current Days Payable of 200.52 is 188% above median its 10-year median of 69.55. Over the past 10 years, this metric has ranged from a low of 37.68 to a high of 4,440.83. The Medical Diagnostics & Research industry median Days Payable is 65.01. Clearbridge Health's value of 200.52 is 208.5% above this industry median. Based on the distribution chart, Clearbridge Health ranks #80 out of 190 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does Clearbridge Health's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clearbridge Health ranks #80 out of 190 companies for Days Payable. This puts Clearbridge Health in the upper half of its industry. The industry median Days Payable is 65.01. Clearbridge Health's value of 200.52 is 208.5% above this benchmark. Historically, Clearbridge Health's own Days Payable has ranged from 37.68 to 4,440.83 over the past decade. While the company's 10-year median is 69.55 vs. the industry median of 65.01, Clearbridge Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.01, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clearbridge Health's current Days Payable of 200.52 is 208.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clearbridge Health and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clearbridge Health's current Days Payable is 200.52, which is 188% above median its own 10-year median of 69.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearbridge Health stock overvalued right now?
Clearbridge Health (SGX:1H3) has a current Days Payable of 200.52. The current Days Payable is 200.52, which is 188% above median its 10-year median of 69.55 and 208.5% above the Medical Diagnostics & Research industry median of 65.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clearbridge Health (SGX:1H3), the current Days Payable is 200.52 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments are Strategic investments; Others ; Medical clinics; Corporate segment and Investment. It derives key revenue from the Medical clinics segment. The medical clinics/centres segment involves the provision of general medical, dental and clinical services and distribution of the medical and pharmaceutical products. The group has a business presence in Singapore, Philippines, Hong Kong, Malaysia and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1H3 has been successfully added to your 
